Elevated Serum Concentration of Adipose-Derived Factor, Adiponectin, in Patients With Type 1 Diabetes
Akihisa Imagawa(The University of Osaka), Yūji Matsuzawa(Sumitomo Hospital), Kazuya Yamagata(Kumamoto University), Tadashi Nakamura(Kawasaki Hospital), K. Sayama(The University of Osaka), Sachiyo Tanaka(Nippon Veterinary and Life Science University), Hiromi Iwahashi(Toyonaka Municipal Hospital), Makoto Moriwaki(The University of Osaka), Tohru Funahashi(The University of Osaka), Hitoshi Nishizawa(Osaka Gakuin University), Jun-ichiro Miyagawa(The University of Osaka), Sae Uno(The University of Osaka)
Cited by 157
Related Papers
Hypoadiponectinemia in Obesity and Type 2 Diabetes: Close Association with Insulin Resistance and Hyperinsulinemia
|The Journal of Clinical Endocrinology & Metabolism|2001|3.4k
Weight Reduction Increases Plasma Levels of an Adipose-Derived Anti-Inflammatory Protein, Adiponectin
|The Journal of Clinical Endocrinology & Metabolism|2001|1.2k
Adiponectin and development of type 2 diabetes in the Pima Indian population
|The Lancet|2002|1.1k
Adiponectin, Metabolic Risk Factors, and Cardiovascular Events among Patients with End-Stage Renal Disease
|Journal of the American Society of Nephrology|2002|764